Determination of r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10- tetrahydrobenzo[α]pyrene in human urine by gas chromatography/negative ion chemical ionization/mass spectrometry

Chemical Research in Toxicology

Volumn 13, Issue 4, 2000, Pages 271-280

  Simpson, Christopher D ^a   Wu, Ming Tsang ^b   Christiani, David C ^b   Santella, Regina M ^c   Carmella, Steven G ^a   Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE DERIVATIVE; COAL TAR;

ARTICLE; CIGARETTE SMOKING; DETOXIFICATION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION MONITORING; MASS SPECTROMETRY; PSORIASIS; SOLID PHASE EXTRACTION; URINALYSIS;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; BENZO(A)PYRENE; CARCINOGENS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS;

EID: 0034012497     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx990202c     Document Type: Article

References (58)

1. International Agency for Research on Cancer (1983) Polynuclear Aromatic Compounds, Part 1, Chemical, Environmental, and Experimental Data, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 32, pp 33-91, IARC, Lyon, France.
2. International Agency for Research on Cancer (1984) Polynuclear Aromatic Compounds, Part 3, Industrial Exposures in Aluminium Production, Coal Gasification, Coke Production, and Iron and Steel Founding, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 34, pp 65-131, IARC, Lyon, France.
3. International Agency for Research on Cancer (1985) Polynuclear Aromatic Compounds, Part 4, Bitumens, Coal-Tars and Derived Products, Shale-oils and Soots, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 35, pp 83-247, IARC, Lyon, France.
4. Hoffmann, D., and Hecht, S. S. (1990) Advances in tobacco carcinogenesis. In Handbook of Experimental Pharmacology (Cooper, C. S., and Grover, P. L., Eds.) pp 63-102, Springer-Verlag, Heidelberg, Germany.
5. Hecht, S. S. (1999) Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 91, 1194-1210.
6. International Agency for Research on Cancer (1973) Certain polycyclic aromatic hydrocarbons and heterocyclic compounds, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 3, pp 91-136, IARC, Lyon, France.
7. Hecht, S. S. (1988) Potential carcinogenic effects of polynuclear aromatic hydrocarbons and nitroaromatics in mobile source emissions. In Air Pollution, The Automobile, and Public Health (Watson, A. Y., Bates, R. R., and Kennedy, D., Eds.) pp 555-578, National Academy Press, Washington, DC.
8. Culp, S. J., Gaylor, D. W., Sheldon, W. G., Goldstein, L. S., and Beland, F. A. (1998) A comparison of the tumors induced by coal tar and benzo[a]pyrene in a two-year bioassay. Carcinogenesis 19, 117-124.
9. Cooper, C. S., Grover, P. L., and Sims, P. (1983) The metabolism and activation of benzo[a]pyrene. Prog. Drug Metab. 7, 295-396.
10. Bauer, E., Guo, Z., Ueng, Y.-F., Bell, L. C., Zeldin, D., and Guengerich, F. P. (1995) Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. 8, 136-142.
11. Shou, M., Korzekwa, K. R., Crespi, C. L., Gonzalez, F. J., and Gelboin, H. V. (1994) The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo-[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Mol. Carcinog. 10, 159-168.
12. Kim, J. H., Stansbury, K. H., Walker, N. J., Trush, M. A., Strickland, P. T., and Sutter, T. R. (1999) Metabolism of benzo-[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 19, 1847-1853.
13. Shimada, T., Gillam, E. M. J., Oda, Y., Tsumura, F., Sutter, T. R., Guengerich, F. P., and Inoue, K. (1999) Metabolism of benzo-[a]pyrene to trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase. Chem. Res. Toxicol. 12, 623-629.
14. Conney, A. H. (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res. 42, 4875-4917.
15. Thakker, D. R., Yagi, H., Levin, W., Wood, A. W., Conney, A. H., and Jerina, D. M. (1985) Polycyclic aromatic hydrocarbons: metabolic activation to ultimate carcinogens. In Bioactivation of Foreign Compounds (Anders, M. W., Ed.) pp 177-242, Academic Press, New York.
16. Baird, W. M., and Ralston, S. L. (1997) Carcinogenic polycyclic aromatic hydrocarbons. In Comprehensive Toxicology: Vol. 12, Chemical Carcinogens and Anticarcinogens (Bowden, G. T., and Fischer, S. M., Eds.) pp 171-200, Elsevier Science Ltd., New York.
17. Geacintov, N. E., Cosman, M., Hingerty, B. E., Amin, S., Broyde, S., and Patel, D. J. (1997) NMR solution structures of stereoisomeric covalent polycyclic aromatic carcinogen-DNA adducts: principles, patterns, and diversity. Chem. Res. Toxicol. 10, 112-146.
18. Szeliga, J., and Dipple, A. (1998) DNA adduct formation by polycyclic aromatic hydrocarbon dihydrodiol epoxides. Chem. Res. Toxicol. 11, 1-11.
19. Denissenko, M. F., Pao, A., Tang, M., and Pfeifer, G. P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hot spots in P53. Science 274, 430-432.
20. Penning, T. M., Burczynski, M. E., Hung, C.-F., McCoull, K. D., Palackal, N. T., and Tsuruda, L. S. (1999) Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: Generation of reactive and redox active o-quinones. Chem. Res. Toxicol. 12, 1-18.
21. Rogan, E. G., Devanesan, P. D., RamaKrishna, N. V. S., Higginbotham, S., Padmavathi, N. S., Chapman, K., Cavalieri, E. L., Jeong, H., Jankowiak, R., and Small, G. J. (1993) Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skin. Chem. Res. Toxicol. 6, 356-363.
22. Chen, L., Devanesan, P. D., Higginbotham, S., Ariese, F., Jankowiak, R., Small, G. J., Rogan, E. G., and Cavalieri, E. L. (1996) Expanded analysis of benzo[a]pyrene-DNA adducts formed in vitro and in mouse skin: their significance in tumor initiation. Chem. Res. Toxicol. 9, 897-903.
23. Bartsch, H. (1996) DNA adducts in human carcinogenesis: etiological relevance and structure-activity relationship. Mutat. Res. 340, 67-79.
24. Perera, F. P. (1996) Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J. Natl. Cancer Inst. 88, 496-509.
25. Spivack, S. D., Fasco, M. J., Walker, V. E., and Kaminsky, L. S. (1997) The molecular epidemiology of lung cancer. Crit. Rev. Toxicol. 27, 319-365.
26. Taningher, M., Malacarne, D., Izzotti, A., Ugolini, D., and Parodi, S. (1999) Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat. Res. 436, 227-261.
27. Rebbeck, T. R. (1997) Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol., Biomarkers Prev. 6, 733-743.
28. Santella, R. M., Gomes-Nunes, M., Blaskovic, R., Perera, F. P., Tang, D., Beachman, A., Lin, J.-H., and DeLeo, V. A. (1994) Quantitation of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar treated psoriasis patients and untreated volunteers. Cancer Epidemiol., Biomarkers Prev. 3, 137-140.
29. Wu, M.-T., Mao, I. F., Wypij, D., Ho, C.-K., Chen, J. R., and Christiani, D. C. (1997) Serum liver function profiles in coking workers. Am. J. Ind. Med. 60, 105-110.
30. 3I postlabelling of released tetraols. Chem. Res. Toxicol. 9, 508-516.
31. Melikian, A. A., Sun, P., Pierpont, C., Coleman, S., and Hecht, S. S. (1997) Gas chromatography-mass spectrometric determination of benzo[a]pyrene and chrysene diol epoxide globin adducts in humans. Cancer Epidemiol., Biomarkers Prev. 6, 833-839.
32. Hecht, S. S., Carmella, S. G., Chen, M., Koch, J. F. D., Miller, A. T., Murphy, S. E., Jensen, J. A., Zimmerman, C. L., and Hatsukami, D. K. (1999) Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res. 59, 590-596.
33. Wilson, I. D., Morgan, E. D., and Murphy, S. J. (1990) Sample preparation for the chromatographic determination of ecdysteroids using solid-phase extraction methods. Anal. Chim. Acta 236, 145-155.
34. Ciucanu, I., and Kerek, F. (1984) A simple and rapid method for the permethylation of carbohydrates. Carbohydr. Res. 134, 209-217.
35. Weston, A., Bowman, E. D., Carr, P., Rothman, N., and Strickland, P. T. (1993) Detection of metabolites of polycyclic aromatic hydrocarbons in human urine. Carcinogenesis 14, 1053-1055.
36. Bowman, E. D., Rothman, N., Hackl, C., Santella, R. M., and Weston, A. (1997) Interindividual variation in the levels of certain urinary polycyclic aromatic hydrocarbon metabolites following medicinal exposure to coal tar ointment. Biomarkers 2, 321-327.
37. Bentsen-Farmen, R. K., Botnen, I. V., Noto, H., Jacob, J., and Ovrebo, S. (1999) Detection of polycyclic aromatic hydrocarbon metabolites by high-pressure liquid chromatography after purification on immunoaffinity columns in urine from occupationally exposed workers. Int. Arch. Occup. Environ. Health 72, 161-168.
38. Hoffmann, D., and Hoffmann, I. (1997) The changing cigarette, 1950-1995. J. Toxicol. Environ. Health 50, 307-364.
39. Strickland, P., Kang, D., and Sithisarankul, P. (1996) Polycyclic aromatic hydrocarbon metabolites in urine as biomarkers of exposure and effect. Environ. Health Perspect. 104 (Suppl. 5), 927-932.
40. Bouchard, M., and Viau, C. (1999) Urinary 1-hydroxypyrene as a biomarker of exposure to polycyclic aromatic hydrocarbons: biological monitoring strategies and methodology for determining biological exposure indices for various work environments. Biomarkers 4, 159-187.
41. Jongeneelen, F. J. (1997) Methods for routine biological monitoring of carcinogenic PAH-mixtures. Sci. Total Environ. 199, 141-149.
42. Ariese, F., Verkaik, M., Hoornweg, G. P., van de Nesse, R. J., Jukema-Leenstra, S. R., Hofstraat, J. W., Gooijer, C., and Velthorst, N. H. (1994) Trace analysis of 3-hydroxybenzo[a]pyrene in urine for the biomonitoring of human exposure to polycyclic aromatic hydrocarbons. J. Appl. Toxicol. 18, 195-204.
43. Grimmer, G., Jacob, J., Dettbarn, G., and Naujack, K.-W. (1997) Determination of urinary metabolites of polycyclic aromatic hydrocarbons (PAH) for the risk assessment of PAH-exposed workers. Int. Arch. Occup. Environ. Health 69, 231-239.
44. Johnson, C., and Greenberg, A. (1999) Extraction and high-performance liquid chromatographic separation of selected pyrene and benzo[a]pyrene sulfates and glucuronides: preliminary application to the analysis of smokers' urine. J. Chromatogr. B 728, 209-216.
45. China with high lung cancer mortality associated with exposure to unvented coal smoke. Carcinogenesis 16, 3031-3036.
46. Becher, G., and Bjorseth, A. (1983) Determination of exposure to polycyclic aromatic hydrocarbons by analysis of human urine. Cancer Lett. 17, 301-311.
47. Nakajima, M., Yokoi, T., Mizutani, M., Shin, S., Kadlubar, F. F., and Kamataki, T. (1994) Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene. Cancer Epidemiol., Biomarkers Prev. 3, 413-421.
48. Heidelberger, C., and Weiss, S. M. (1951) The distribution of radioactivity in mice following administration of 3,4-benzpyrene-5-C14 and 1,2,5,6-dibenzanthracene-9,10-C14. Cancer Res. 11, 885-891.
49. Kotin, P., Falk, H. L., and Busser, R. (1959) Distribution, retention, and elimination of C14-3,4-benzpyrene after administration to mice and rats. J. Natl. Cancer Inst. 23, 541-555.
50. Falk, H. L., Kotin, P., and Lee, S. S. (1962) Intermediary metabolism of benzo[a]pyrene in the rat. J. Natl. Cancer Inst. 28, 699-724.
51. Hecht, S. S., Grabowski, W., and Groth, K. (1979) Analysis of feces for benzo[a]pyrene after consumption of charcoal-broiled beef by rats and humans. Food Cosmet. Toxicol. 17, 223-227.
52. Kaderlik, K. R., and Kadlubar, F. F. (1995) Metabolic polymorphisms and carcinogen-DNA adduct formation in human populations. Pharmacogenetics 5, S108-S117.
53. Li, M., Hurtubise, R. J., and Weston, A. (1999) Determination of benzo[a]pyrene-DNA adducts by solid-matrix phosphorescence. Anal. Chem. 71, 4679-4683.
54. Pastorelli, R., Restano, J., Guanci, M., Maramonte, M., Magagnotti, C., Allevi, R., Lauri, D., Fanelli, R., and Airoldi, L. (1996) Hemoglobin adducts of benzo[a]pyrene diolepoxide in newspaper vendors: association with traffic exhaust. Carcinogenesis 17, 2389-2394.
55. Pastorelli, R., Guanci, M., Cerri, A., Negri, E., La Vecchia, C., Fumagalli, F., Mezzetti, M., Cappelli, R., Panigalli, T., Fanelli, R., and Airoldi, L. (1998) Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome 450 enzymes on DNA, and blood protein adducts of benzo[a]pyrene-diolepoxide. Cancer Epidemiol., Biomarkers Prev. 7, 703-709.
56. Pastorelli, R., Guanci, M., Restano, J., Berri, A., Micoli, G., Minoia, C., Alcini, D., Carrer, P., Negri, E., La Vecchia, C., Fanelli, R., and Airoldi, L. (1999) Seasonal effect on airborne pyrene, urinary 1-hydroxypyrene, and benzo[a]pyrene diol epoxide-hemoglobin adducts in the general population. Cancer Epidemiol., Biomarkers Prev. 8, 561-565.
57. Lin, B., Doan, L., Yagi, H., Jerina, D. M., and Whalen, D. L. (1998) Halide effects in the hydrolysis reactions of (±)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10- tetrahydro-benzo[a]pyrene. Chem. Res. Toxicol. 11, 630-638.
58. Yang, Y., Sjovall, J., Rafter, J., and Gustafsson, J.-A. (1994) Characterization of neutral metabolites of benzo[a]pyrene in urine from germfree rats. Carcinogenesis 15, 681-687.